DCM is the leading cause of heart failure in patients with chronic diabetes. However, the underlying mechanisms of DCM are poorly understood, and treatment options are limited.
FDA approves high-risk neuroblastoma treatment for kids and adults
The FDA approved US WorldMeds’ eflornithine as a therapy to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma who have